HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,911,000 | +7.3% | 32,495 | +2.0% | 0.00% | +33.3% |
| Q2 2023 | $2,713,000 | +9.4% | 31,861 | +6.3% | 0.00% | 0.0% |
| Q1 2023 | $2,480,000 | +13.7% | 29,974 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $2,182,000 | -28.3% | 27,748 | -31.7% | 0.00% | -25.0% |
| Q3 2022 | $3,045,000 | +1.5% | 40,600 | -11.8% | 0.00% | +33.3% |
| Q2 2022 | $2,999,000 | +3.2% | 46,018 | +0.1% | 0.00% | +50.0% |
| Q1 2022 | $2,906,000 | +23.0% | 45,967 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $2,363,000 | -23.1% | 44,555 | +2.4% | 0.00% | -33.3% |
| Q3 2021 | $3,072,000 | +19.9% | 43,516 | +13.2% | 0.00% | +50.0% |
| Q2 2021 | $2,562,000 | -34.4% | 38,445 | +9.2% | 0.00% | -66.7% |
| Q1 2021 | $3,908,000 | +1066.6% | 35,203 | +1146.6% | 0.01% | – |
| Q4 2020 | $335,000 | +36.2% | 2,824 | 0.0% | 0.00% | – |
| Q3 2020 | $246,000 | -98.4% | 2,824 | -98.3% | 0.00% | -100.0% |
| Q2 2020 | $15,286,000 | +25.4% | 170,678 | +39.5% | 0.03% | +4.0% |
| Q1 2020 | $12,190,000 | -22.2% | 122,316 | -10.3% | 0.02% | +13.6% |
| Q4 2019 | $15,663,000 | -0.2% | 136,315 | +9.5% | 0.02% | -15.4% |
| Q3 2019 | $15,702,000 | -67.6% | 124,478 | -69.1% | 0.03% | -7.1% |
| Q2 2019 | $48,495,000 | +396.4% | 402,981 | +260.9% | 0.03% | +64.7% |
| Q1 2019 | $9,769,000 | -39.5% | 111,675 | -30.8% | 0.02% | -45.2% |
| Q4 2018 | $16,139,000 | -14.0% | 161,308 | -1.5% | 0.03% | 0.0% |
| Q3 2018 | $18,769,000 | -60.3% | 163,809 | -69.0% | 0.03% | -62.2% |
| Q2 2018 | $47,313,000 | +3.4% | 527,578 | -15.6% | 0.08% | -1.2% |
| Q1 2018 | $45,749,000 | +16.3% | 625,335 | -7.7% | 0.08% | +18.6% |
| Q4 2017 | $39,329,000 | +28.3% | 677,150 | -0.9% | 0.07% | +27.3% |
| Q3 2017 | $30,650,000 | +23.5% | 683,071 | +8.7% | 0.06% | +22.2% |
| Q2 2017 | $24,823,000 | +0.4% | 628,586 | +3.1% | 0.04% | 0.0% |
| Q1 2017 | $24,724,000 | +3.6% | 609,428 | +2.6% | 0.04% | -2.2% |
| Q4 2016 | $23,872,000 | +9.2% | 593,835 | -1.6% | 0.05% | +9.5% |
| Q3 2016 | $21,863,000 | -37.9% | 603,778 | -50.3% | 0.04% | +23.5% |
| Q2 2016 | $35,204,000 | +39.8% | 1,214,344 | +68.7% | 0.03% | -33.3% |
| Q1 2016 | $25,181,000 | -21.9% | 719,861 | -28.1% | 0.05% | -22.7% |
| Q4 2015 | $32,262,000 | +2.0% | 1,000,684 | +2.3% | 0.07% | -2.9% |
| Q3 2015 | $31,619,000 | -20.4% | 978,319 | +1.9% | 0.07% | -13.9% |
| Q2 2015 | $39,723,000 | -7.4% | 960,409 | +0.5% | 0.08% | -6.0% |
| Q1 2015 | $42,919,000 | +52.3% | 955,454 | +26.9% | 0.08% | +44.8% |
| Q4 2014 | $28,185,000 | +29.1% | 753,210 | +20.5% | 0.06% | +23.4% |
| Q3 2014 | $21,835,000 | -1.0% | 625,298 | +0.0% | 0.05% | -4.1% |
| Q2 2014 | $22,059,000 | -0.7% | 625,252 | -8.2% | 0.05% | +28.9% |
| Q1 2014 | $22,205,000 | -37.0% | 681,334 | -18.6% | 0.04% | -39.7% |
| Q4 2013 | $35,269,000 | +24.1% | 837,146 | +17.4% | 0.06% | +12.5% |
| Q3 2013 | $28,431,000 | -2.4% | 712,914 | +1.2% | 0.06% | -12.5% |
| Q2 2013 | $29,137,000 | – | 704,655 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |